EV / EBITDA společnosti Intercept Pharmaceuticals Inc
Jaká je hodnota metriky EV / EBITDA společnosti Intercept Pharmaceuticals Inc?
Hodnota metriky EV / EBITDA společnosti Intercept Pharmaceuticals Inc je N/A
Jaká je definice metriky EV / EBITDA?
EV/EBITDA je podniková hodnota dělená EBITDA (zisk před odečtením úroků, daní, odpisů a amortizací). Měří nákladnost akcie a používá se k porovnání společností mezi sebou častěji než P/E ratio. Měří cenu, jakou investor zaplatí za pohyb hotovosti ve společnosti.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Intercept Pharmaceuticals Inc
Čemu se věnuje společnost Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Firmy s metrikou ev / ebitda podobnou společnosti Intercept Pharmaceuticals Inc
- Hodnota metriky EV / EBITDA společnosti Balyo SA je N/A
- Hodnota metriky EV / EBITDA společnosti Vicon je N/A
- Hodnota metriky EV / EBITDA společnosti 908 Devices je N/A
- Hodnota metriky EV / EBITDA společnosti CloudMD Software & Services je N/A
- Hodnota metriky EV / EBITDA společnosti CanAlaska Uranium je N/A
- Hodnota metriky EV / EBITDA společnosti NatureBank Asset Management je N/A
- Hodnota metriky EV / EBITDA společnosti Intercept Pharmaceuticals Inc je N/A
- Hodnota metriky EV / EBITDA společnosti Rincon Resources je N/A
- Hodnota metriky EV / EBITDA společnosti Copper Search je N/A
- Hodnota metriky EV / EBITDA společnosti A.I.S. Resources je N/A
- Hodnota metriky EV / EBITDA společnosti UCapital24 S.p.A je N/A
- Hodnota metriky EV / EBITDA společnosti Health Catalyst Inc je N/A
- Hodnota metriky EV / EBITDA společnosti Syncora je N/A